Cryoablation for Monomorphic Ventricular Tachycardia
Running, not enrolling · Not applicable
Conditions studied: Sustained VT
In brief
The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
Key facts
- Study ID
- NCT05675865
- Run by
- Adagio Medical
- People needed
- 206
- Starts
- 2023-09-11
- Expected to finish
- 2027-03-30
- Last updated by the study team
- 2026-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner University Medical Center Phoenix — Phoenix, Arizona, United States
- University of California San Francisco — San Francisco, California, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Weill Cornell Medical Center — New York, New York, United States
- Northwell Health- Staten Island University Hospital — Staten Island, New York, United States
- Ohio State University — Columbus, Ohio, United States
- Hospital of University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Medical Center of South Carolina (MUSC) — Charleston, South Carolina, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- Texas Cardiac Arrhythmia Research Institute (TCARF) — Austin, Texas, United States
- Montreal Heart Institute — Montreal, Quebec, Canada
- McGill University — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.